Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2073397

O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F.c1ccc(-[n+]2ccccc2)cc1.c1ccc(-[n+]2ccccc2)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.41
DPP4 P27487 2/20 0.39
DPP7 Q9UHL4 2/20 0.39
DPP9 Q86TI2 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
NPSR1 Q6W5P4 2/20 0.37
KCNN1 Q92952 1/20 0.37
DPP8 Q6V1X1 1/20 0.36
HDAC6 Q9UBN7 5/20 0.35
HDAC3 O15379 4/20 0.35
HDAC4 P56524 4/20 0.35
HDAC1 Q13547 4/20 0.35
HDAC7 Q8WUI4 4/20 0.35
HDAC2 Q92769 4/20 0.35
HDAC10 Q969S8 4/20 0.35
HDAC11 Q96DB2 4/20 0.35
HDAC8 Q9BY41 4/20 0.35
HDAC9 Q9UKV0 4/20 0.35
HDAC5 Q9UQL6 4/20 0.35
CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2160555 1.00 CES1 (0.41) CES1DPP4DPP7DPP9TDP1
Trifluoroacetic Acid SCHEMBL2073398 0.96 TDP1 (0.41) CES1DPP4DPP7DPP9TDP1
Trifluoroacetic Acid SCHEMBL20641374 0.80 TDP1 (0.36) CES1TDP1KCNN1HDAC6HDAC3
Trifluoroacetic Acid SCHEMBL2160769 0.79 CES1 (0.34) CES1TDP1NPSR1KCNN1HDAC6
Trifluoroacetic Acid SCHEMBL4413284 0.77 TDP1 (0.39) CES1TDP1KCNN1HDAC6HDAC3
Trifluoromethanesulfonic Acid SCHEMBL30570819 0.77 GPR3 (0.46) CA2
SCHEMBL125499 0.76 MAPT (0.35) TDP1HDAC8CA2CA4
Trifluoroacetic Acid SCHEMBL2160765 0.74 TDP1 (0.39) CES1DPP4DPP7DPP9TDP1
Ammonia Solution, Strong SCHEMBL4202272 0.73 MAPT (0.34) HDAC8
SCHEMBL28558026 0.73 MAPT (0.34) HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863294-B2 Heterocycle derivatives as histone deacetylase (HDAC) inhibitors INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-01-04 US disclosed
US-20090048228-A1 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048228-A1 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC5, HDAC11 CES1 2207/4885DPP4 2060/4885DPP7 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.